Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+12.2%
5Y CAGR+15.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+12.2%/yr
vs +17.0%/yr prior
5Y CAGR
+15.5%/yr
Recent deceleration
Acceleration
-4.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
3 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.75B | +3.4% |
| 2024 | $3.63B | +14.8% |
| 2023 | $3.16B | +19.1% |
| 2022 | $2.66B | -13.0% |
| 2021 | $3.05B | +66.8% |
| 2020 | $1.83B | +4.3% |
| 2019 | $1.75B | +23.9% |
| 2018 | $1.42B | +6.9% |
| 2017 | $1.32B | +26.4% |
| 2016 | $1.05B | - |